The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF: Announcement of Newly Elected Leadership

CDDF: Announcement of Newly Elected Leadership

The Cancer Drug Development Forum Announces Newly Elected Leadership The Cancer Drug Development Forum (CDDF) is delighted to announce newly elected leadership, appointed at its General Assembly on 1 June 2022. Please join us in welcoming former...
CDDF Annual Report 2021

CDDF Annual Report 2021

The CDDF has published its 2021 annual report which highlights the steps the association has taken to further its mission in the year in order to stimulate advancement in cancer drug development and access. To read the report, click the following link: CDDF Annual...
European Pharmaceutical Review (Dec, 2021): CDDF Article

European Pharmaceutical Review (Dec, 2021): CDDF Article

The CDDF’s article on “United efforts to accelerate drug development” has been published in the European Pharmaceutical Review (Dec, 2021). In the article, Prof. John Smyth (Chairman), Prof. Axel Glasmacher (Treasurer) and Prof. Jaap Verweij...
Happy Christmas!

Happy Christmas!

The CDDF team wishes you a happy holiday season! Thank you for your continued support and collaboration in 2021.

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70